List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 362 studies with search of:   "Melphalan"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
Condition: Newly Diagnosed, Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: melphalan, prednisone;   Drug: melphalan, prednisone, thalidomide
2 Recruiting A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Liposomal Doxorubicin/Melphalan/Bortezomib
3 Active, not recruiting Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
Conditions: Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Allogeneic Marrow Transplant
Interventions: Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
4 Recruiting Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients
Conditions: Multiple Myeloma;   Newly Diagnosed Patients
Interventions: Drug: Melphalan;   Drug: Lenalidomide
5 Recruiting Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Melphalan
6 Recruiting Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
Conditions: Central Nervous System Tumors;   Tumors
Intervention: Drug: thiotepa melphalan
7 Recruiting Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: Melphalan, Bortezomib
8 Recruiting Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-Diagnosed Light-Chain (AL)-Amyloidosis
Condition: Amyloidosis
Interventions: Drug: Lenalidomide;   Drug: Melphalan;   Drug: Dexamethasone
9 Recruiting Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy
Condition: Multiple Myeloma
Intervention: Drug: Melphalan
10 Completed Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
Conditions: Multiple Myeloma;   Stem Cell Transplantation
Interventions: Drug: Arsenic Trioxide;   Drug: Melphalan;   Drug: Ascorbic Acid
11 Recruiting Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
Conditions: Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Busulfan;   Drug: Gemcitabine;   Drug: Melphalan;   Other: Hematopoietic Cell Transplantation;   Drug: Rituximab for Patients with B-Cell Malignancies
12 Active, not recruiting Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
Condition: Myeloma
Interventions: Drug: Trisenox (Arsenic Trioxide);   Drug: Velcade (Bortezomib);   Drug: Melphalan;   Drug: Vitamin C (Ascorbic Acid)
13 Recruiting Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Melphalan;   Procedure: Stem Cell Transplant
14 Recruiting Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
Conditions: Multiple Myeloma;   Lymphoma
Interventions: Drug: Busulfan;   Drug: Melphalan
15 Recruiting Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
Condition: Multiple Myeloma
Interventions: Drug: melphalan;   Drug: topotecan;   Procedure: Bone Marrow Transplant
16 Completed A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
Condition: Melanoma
Interventions: Drug: melphalan;   Drug: tumor necrosis factor;   Drug: interferon-gamma;   Procedure: hyperthermic isolated limb perfusion
17 Active, not recruiting Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
Conditions: Multiple Myeloma;   Plasma Cell Leukemia
Interventions: Drug: Bortezomib;   Drug: Melphalan;   Procedure: stem cell transplant
18 Not yet recruiting A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients
Condition: Multiple Myeloma
Intervention: Drug: Bortezomib; Melphalan; Prednisone; Velcade
19 Recruiting Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone;   Drug: filgrastim;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation
20 Recruiting Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
Conditions: Nausea;   Vomiting
Interventions: Drug: Carmustine, Etoposide, Cytarabine, Melphalan;   Drug: Aprepitant, Carmustine, Etoposide, Cytarabine, Melphalan

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services